BTG2 and glioblastoma: Thus, it is argued that GBM‐derived EVs are internalised by GBM cells and release miR‐27a‐3p into GBM cells, resulting in higher expression of miR‐ 27a‐3p, targeting BTG2 and improving TMZ obstruction.